A trial looking at stereotactic ablative radiotherapy for non small cell lung cancer (SARON)

[OllieScott]

This trial is funded by CRUK, sponsored by UCL and coordinated at UCL Cancer Trials Centre (UCL CTC) in London. We are unable to help advise on individual patient cases as our function is administrative and we are not affiliated to any UK hospital or healthcare institution. Patients or their relatives should ask their treating doctor if they are interested in participating in the trial.

The Chief Investigator of this trial is Dr David Lindau. Currently we have 12 centres throughout the UK hoping to have about 30 centres in total. Here is some information about the trial hosted at CRUK website: cancerresearchuk.org/about-...

The patient population that we are looking at is stage IV non small cell lung cancer, with metastatic disease (not more than 3 areas). SARON is a randomised trial where patients will have either chemotherapy only (standard) or chemotherapy plus radiotherapy (it could be conventional radiotherapy, or stereotactic ablative radiotherapy (SABR) and/or stereotactic radiosurgery (SRS).

For further information about the trial, please contact Ka Man Condne, Trial Coordinator. Telephone number: 0207 679 9857. Email: [e-mail]